Author: admin

What is Google Ads? Google Ads is Google’s digital marketing platform where business owners pay for their advertisements to appear in Google search engine results and on Google applications like Google Maps and YouTube. Setting up a Google Ads account Creating a Google Ads account is free, and business owners are welcome to explore what the program offers before setting a budget for their campaign. Business owners simply fill out a brief survey describing their business and goals for the campaign. Ad campaigns are strengthened by claiming your business through a business profile, but this is not required. Before starting…

On February 20, one of the most popular Hungarian cryptocurrencies, the Hungarian Vizsla Inu (HVI), will host a token burn. The fast-paced digital currency is doing so at the request of holders, that is, current Vizsla money owners. “A good large percentage of the holders wanted the burning. We weren’t basically on the side of this, but since it’s a community token, if we didn’t listen to our moonlighters, we wouldn’t be the ones,” said Dániel Kádár, a member of the HVI team. The rest will be more valuable Token burning is done for the benefit of the current owners…

Genomic cancer testing company Veracyte is moving to acquire Decipher Biosciences in a $600 million deal, with the goal of broadening its diagnostic reach to seven of the 10 most common tumor types affecting over 1 million new patients per year. Decipher, once known as GenomeDx, maintains its own portfolio of tests focused on urologic cancers, including whole-transcriptome analysis and machine-learning-based algorithms. Its prostate test is currently included in national cancer treatment guidelines, while its kidney and bladder cancer tests are currently under development, with the latter expected to launch commercially this year. Sponsored By Syneos Health Blazing a Trail…

Valley Forge, PA (February 2, 2021) – Today, AmerisourceBergen kicked off its first-ever ThinkLive Commercialization global event, a new extension to its annual manufacturer summit centred on strategies and opportunities for manufacturers that are bringing new products to market. The COVID-19 pandemic has disrupted research and development efforts and created new challenges throughout the commercialization journey. Over the three-day virtual summit, AmerisourceBergen leaders will share market access and commercialization strategies, innovative solutions to increase patient access, and how the company will collaborate with manufacturers at each step of the commercialization process to drive product success. “This is a critically important…

Canon Medical is expanding the clinical reach of its artificial intelligence programs designed to improve MRI image quality, saying it can now be used in 96% of all scanning procedures. The company’s Advanced intelligent Clear-IQ Engine, or AiCE, aims to sharpen scans taken by lower-dose, 1.5 Tesla MRIs, to bring their image quality up to par with 3.0 Tesla machines. The system was previously cleared by the FDA for certain brain- and knee-focused indications, using Canon Medical’s Vantage Orian 1.5 Tesla system. Now its applications span all joints, as well as cardiac, abdomen, spine and pelvic scans. Sponsored By Syneos…

Eric-Theodore Yepao is the CEO and founder of Nordland Holding Europe GmbH, a company that creates private cities. A private city offers residents the basic services of a state within a defined territory with all rights and obligations being defined by contractual obligations. Currently, he has dealings all over the world including cities like Paris, France. Eric-Theodore attended Harvard University and became involved in investment banking. He felt disillusioned with investing in countries that violated human rights or in companies that did not give back to the communities where it is present. He then became passionate about corporate responsibility. Eric-Theodore…

MISSISSAUGA, ON. December 24, 2020 – FedEx Express Canada, a subsidiary of FedEx Corp., and Innomar Strategies, announced today that the country’s first operations to distribute the Moderna COVID-19 vaccine in Canada on behalf of the Government of Canada are underway. The first shipment arrives at the FedEx Express Canada hub in Toronto this afternoon. Part of this initial shipment will continue onwards to the territories to facilitate vaccine distribution in Canada’s northern regions. The vaccine roll-out will be facilitated by the vast FedEx Express Canada network, utilizing the specialized, cold-chain storage and packaging capabilities of Innomar Strategies, a part of AmerisourceBergen…

Technology in the healthcare landscape is evolving, and leading hub services providers are implementing solutions that help accelerate speed to therapy for patients. One crucial portion of accessing medication is being able to receive benefit verification information in a timely manner. The rise of electronic benefits verification (eBV) has helped healthcare providers minimize time going back and forth with payers via phone or fax, making it possible for them to spend more time on patient care. When done right, eBV gives providers and patient support specialists accurate and up-to-date payer information when they need it—not days after the fact. Yet,…

After launching a data analytics collaboration one year and one pandemic ago, the Mayo Clinic and nference say they plan to expand their big data partnership to include research projects in digital pathology and heart rhythm diagnostics. In January 2020, shortly after backing its $60 million Series B round, the Mayo Clinic tapped nference to build an artificial intelligence-powered engine that would take years of clinical records—including millions of tissue slides and physician-written notes—and transform them all into an annotated database capable of being used for research. “We have built a software platform that brings vast, curated quantities of scientific…

As regulators across the world make their way through the submission for what could be the first approved KRAS inhibitor, Amgen is unveiling its biggest data set yet in patients with non-small cell lung cancer (NSCLC). The drug, sotorasib, curbed tumor growth in 81% of patients and shrank tumors in 37% of them. The phase 2 data, to be presented virtually on Friday at the World Conference on Lung Cancer, come from 126 patients with NSCLC whose tumors harbor KRAS G12C mutations and whose cancer has gotten worse despite trying as many as three prior lines of therapy. All 126…